Sign Out
Orally disintegrating tablet: A history of cardiovascular disease, diabetes, seizure, suicide thought. Hypersensitivity.
Oral solution: Gonioscopic evaluation & intraocular pressure monitoring should be performed. Patients with coronary heart disease, liver and kidney disease, hypertension, male patients with a potency of prostate hypertrophy. Discontinue if tardive dyskinesia occur in long-term treatment.
